Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Tips to a Successful Monitoring Visit
Characteristics of research. Designed to derive generalisable new knowledge.
MONITORING DIFFERENT TYPES OF TRIALS. BY OGUNDOKUN OLUSEGUN BIOMEDICAL SCIENTIST / CLINICAL RESEARCH PROFESSIONAL BMLS (LAUTECH), PGD (Clin. Research.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Sharon Harris, Clinical Research Coordinator. SEND PROTOCOLS TO: Clinical Trials Review Committee (CTRC) University Research Administration (URA) Institutional.
Monitoring and Auditing
Turning Questions into Trials: Innovation in Surgical Oncology Jennifer E. Rosen MD FACS Assistant Professor of Surgery and Molecular Medicine Boston University.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
The Pursuit of Better Medicines through Genetic Research Terri Arledge, DVM US Department Head Drug Development Genetics.
ABS Health, LLC 12466, E Washington Blvd, Whittier, CA – Phone
1 Points to Consider of Protocol on Multinational Trial Masaaki Kuwahara, Ph.D. Takeda Chemical Industries, Ltd. The 4th Kitasato-Harvard symposium,
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Why companies saying or should say “YES” to India for Studies.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
RESEARCH PROGRAM UPDATE Sarah Castro, MPH Senior Research Support Liaison.
Minimum Standards and Exemplary Attributes of Clinical Trial Sites S. Gail Eckhardt, MD (Slides prepared by Robin Zon, MD)
Measuring the Feasibility and Cost of PRO-CTCAE Implementation in Trials Presentation to NCI Stakeholders Based on work of the PRO-CTCAE Task 8 (Feasibility)
The SNM Centralized IND & Clinical Trials Network Enabling Implementation Investigational & Approved PET Imaging in Multicenter Clinical Trials George.
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Metals in Medicine Consortium Sydney Cancer Centre.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
The Bartter Research Unit (BRU) as a Vehicle to Support Research at the South Texas Veterans Health Care System March 2009 Research Study Members Training.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Use of Imaging Biomarkers for Regulatory Studies by Peter Steiger J Bone Joint Surg Am Volume 91(Supplement 1): February 1, 2009 ©2009 by The Journal.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Progress of the SNM Clinical Trials Network Michael Graham, PhD, MD Clinical Trials Network Co-Chair SNM President 1.
Pharmacy School Self Study Prof. Abdalla Elkhawad UMST.
How to Start An Industry Sponsored Clinical Trial
Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents Jeff Moscow, MD IDB, CTEP.
SARC Individual and Institutional Participation 2013.
Sponsor Visits and Monitoring
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
The Basque Foundation for Health and Innovation Research Demotek Demonstration Unit of Innovative Technologies in Health An opportunity for.
BRITTANY HAGEN BS RN OCN CCRC CLINICAL RESEARCH MANAGER OHC, INC. OHC Research.
Tania von Hospenthal – Clinical Services Manager British Association of Dermatologists.
REDESIGNING ORGANIZATION & MANAGEMENT SYSTEMS (IHSDNs Attributes # 7, 8, 9,10, 11, 12, 13) (IHSDNs Attributes # 7, 8, 9,10, 11, 12, 13) July , 2015.
Responsibilities of Sponsor, Investigator and Monitor
September 18, 2009 Prepared for DIA GCP QA SIAC teleconference 1 GCP QA for Russia and the Ukraine.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
CLINICAL TRIALS.
CLI and Device Intervention Across the Pacific – An FDA View
Community Health Needs Assessment
Patient Focused Drug Development An FDA Perspective
Responsibilities of Sponsor, Investigator and Monitor
Study Feasibility and Start-up
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
Community Participation in Research
Within Trial Decisions: Unblinding and Termination
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
Jennifer S. Novia INFO 643 March 6, 2011
Cancer Prevention Clinical Trials at [Name of Clinical Site]
South Carolina Clinical & Translational Research Institute (SCTR)
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Getting a Study Done at Jefferson:
Interconnection of good practices: from development to distribution
Presentation transcript:

Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department

Facilities for clinical research allowing the evaluation of pharmaceuticals, medical devices and treatment outcome, with high quality. Scientific and Ethics Committees Experts (trained and certified) in trial management Administrative (contracts, regulatory) and clinical research services Dedicated research space Requirements for Cancer Centers in Clinical Trials (1) 2

Additional criteria may be required for conducting specific trials like : Early phase studies Translational research oriented projects Requirements for Cancer Centers in Clinical Trials (2) 3

As promoter of trials, the EORTC has different sources of information regarding participating institutions: “Membership questionnaire” It includes general information about qualifications of an institution  Type of institution (university, general…..)  Infrastructure of institution (oncology unit, surgery, radiotherapy, imaging, laboratories….……)  Infrastructure of clinical trial unit “Feasibility form” It’s a form prepared by project in order to investigate:  Ability to support the conduct of the trial (staff +local resources)  Potential accrual for a specific patient population  Ability to fulfill protocol requirements (timing of visits, specific tests, collection of samples for translational research, imaging tests (PET/CT/MRI……..), specific storage conditions for biological material or drugs, transfer of material for central review,……) Sources of Information for Cancer Centers (1) 4

“Case Report Forms” These forms are designed by trial in order to capture clinical data that will be used for assessing study endpoints. These forms provide information about the management of patients. Source of Information for Cancer Centers (2) 5

Thank you 6